Neuron Systems, Inc.
Records under this name other than patents Neuron Systems, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,940,721 | Compositions and Methods of Treating Retinal Disease Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,973,025 | Compositions and Methods of Treating Retinal Disease Formerly held In force · High confidence | In force | High confidence | |
| US 8,940,764 | Compositions and methods of treating retinal disease Formerly held In force · High confidence | In force | High confidence | |
| US 12,097,188 | Compositions and Methods for the Treatment of Macular Degeneration Formerly held In force · High confidence | In force | High confidence | |
| US 9,814,701 | Compositions and Methods for the Treatment of Macular Degeneration Formerly held In force · High confidence | In force | High confidence | |
| US 9,604,997 | Peri-Carbinols Formerly held In force · High confidence | In force | High confidence | |
| US 10,111,862 | Novel Traps in the Treatment of Macular Degeneration Formerly held Lapsed on the fee record Ended Oct 30, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 30, 2026 | Low confidence |
| US 11,724,987 | Compositions and Methods of Treating Retinal Disease Formerly held Term ended Term ended Aug 12, 2026 · High confidence | Term ended | Term ended Aug 12, 2026 | High confidence |
| US 10,913,722 | Compositions and Methods of Treating Retinal Disease Held by another company Term ended Term ended Jun 13, 2026 · High confidence | Term ended | Term ended Jun 13, 2026 | High confidence |
| US 9,265,759 | Compositions and Methods of Treating Retinal Disease Formerly held Term ended Term ended May 26, 2026 · Medium confidence | Term ended | Term ended May 26, 2026 | Medium confidence |